Halozyme announces $100M stock offering, shares -3.8% AH

Halozyme Therapeutics (HALO) is selling $100M worth of shares to finance its drug R&D programs, including "potential acceleration" of its PEGPH20 tumor drug development efforts, as well as "general corporate purposes." Underwriters have a $15M overallotment option.

At current levels, the offering stands to increase Halozyme's share count by 6%. The company had $65.3M in cash/investments at the end of September, and $32.3M in debt.

From other sites
Comments (6)
  • Trickdog
    , contributor
    Comments (581) | Send Message
    This $100 Million offering displays huge confidence level by HALO management and may be a clue to a pending takeover offer in the not so distant future possibly, or at least a huge cash reserve for a company with many upcoming catalysts and not far off from cash flow positive. I would rather own HALO over any other biotech company out there, hands down! I have not seen this such a huge opportunity since before I tripled down on Amylin(AMLN) shares and options ahead of their buyout by BMY/AZN 2 years ago(now owned only by AZN).
    3 Feb 2014, 06:39 PM Reply Like
  • Groggy
    , contributor
    Comments (4) | Send Message
    As a channeling trader of this stock since it was pick sheeted I'm 100% in agreement with you. At $13.50 I'm a buyer. With 4th quarter earnings in 3 weeks and 85% of the shares available for a sale and/or merger; the lower it goes the more I'm buying. Something BIG is brewing with HALO.
    5 Feb 2014, 02:17 AM Reply Like
  • Medical Stock Analyst
    , contributor
    Comments (60) | Send Message
    So if I get this right...an offering indicates confidence and higher likelihood of buyout????
    3 Feb 2014, 08:42 PM Reply Like
  • Trickdog
    , contributor
    Comments (581) | Send Message
    The fact that they are raising such a large amount at this time instead of say only $25 to $50 Million, knowing that demand will be high. Also, other stocks such as ACAD have raised money in the past and seeing huge demand and a quick price rise soon after. Buyout potential has been noted by several sources to include Street dot com A. Feurerstein saying HALO will be at the top of the M&A list this year, or similar words. Why do my words bother you, or maybe you have some criticism other than a 'one-liner' addition?
    3 Feb 2014, 10:19 PM Reply Like
  • russleehowe
    , contributor
    Comments (80) | Send Message
    Long on HALO since early November, 2013. Up 24% even after today's 6% sell off. It has steadily climbed. I always like companies to sell more stock -- short term pain for long term gain. This is a keeper. If they don't have $ the research & development come to a screeching halt.
    3 Feb 2014, 11:25 PM Reply Like
  • Mikitrade
    , contributor
    Comments (11) | Send Message
    Thanks for some comments info on Halo. Bought more!
    4 Feb 2014, 04:23 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs